Suche
Mein Konto
Takeover fever in the biotech sector: who is the next candidate?
Discover the takeover fever in the biotech sector! Learn more about potential candidates like Evotec, Bayer and Vidac Pharma after purchasing Morphosys. Who will be taken over next? #Biotech #Takeover #Stocks #Morphosys
Takeover fever in the biotech sector: who is the next candidate?
In the biotech sector, takeover fever recently reached a new level with Genmab, which acquired ProfoundBio for USD 1.8 billion. ProfoundBio, a US biotech company, is focused on developing drugs against ovarian and endometrial cancer. The takeover carousel is also turning in Germany, with the company Morphosys in particular being the focus. Industry experts are now speculating about who could be taken over next. Evotec is often mentioned as a potential candidate, particularly after the biotech company's stock fell sharply due to illicit insider trading, potentially providing an attractive entry opportunity. Another company that is positively highlighted in this context is Vidac Pharma. The company's innovative treatment method has the potential to transform cancer treatment, and recent study results indicate promising advances. Surprisingly, Bayer shares also positioned themselves as one of the daily winners in the DAX. The question of whether this positive trend will continue and whether Bayer can build on this development remains open.